Challenge Series – Driving Customer Profitability With Enterprise Model eClinical Platform And Pricing

Developing new drugs remains exorbitantly expensive, with costs continually on the rise. According to a 2022 report by Deloitte, leading pharmaceutical companies saw an average increase of nearly $300 million in the cost of developing a single new drug, reaching approximately $2.3 billion in total. This underscores why clinical research sponsors heavily invest in potential blockbusters, which sustain research into crucial yet lesser-known therapies.

The challenge lies in enabling sponsors to conduct a broader range of trials, from smaller rare disease therapies to blockbuster candidates, more affordably and efficiently. Crucial Data Solutions (CDS) offers a solution that prioritizes user flexibility, product depth, and advanced technology at a value point conducive to improving the business outcomes of research for life science companies. 

TrialKit is a flexible and scalable platform that allows teams to access and analyze all study data from a single database. This eliminates the need for multiple software platforms and streamlines the clinical trial process. The platform is designed to support both traditional trials and digital clinical trials (DCTs), offering components such as EDC, eSource, eCOA, ePRO, RTSM, eTMF, and eConsent. TrialKit also supports remote data collection and diverse language requirements, making it easier to engage with patients from around the world.

With its advanced technology and value-driven approach, CDS is helping pharmaceutical, biotech, and device companies achieve better business results and increase the number of studies conducted. Access the white paper below to further examine how CDS solutions can enhance cost efficiency in clinical trials for various research stakeholders.